Piramal Enterprises Ltd., incorporated in the year 1947, is a Large Cap company (having a market cap of Rs 22991.67 Crore) operating in Diversified sector.
Piramal Enterprises Ltd. key Products/Revenue Segments include Pharmaceuticals, Interest, Income From Financial Services, Sale of services, Dividend, Other Operating Revenue for the year ending 31-Mar-2022.
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 3726.46 Crore, down -15.33 % from last quarter Total Income of Rs 4401.03 Crore and up 23.74 % from last year same quarter Total Income of Rs 3011.60 Crore . Company reported net profit after tax of Rs 316.78 Crore in latest quarter.
The brokerage initiates coverage with a BUY rating and Sep-23 TP of Rs1,360, based on SOTP methodology, valuing: i) the financial services business using the Excess Return on Equity (ERE) method for a per-share value of Rs845, implying 1.03x of Sep24E BVPS; ii) Investments in
based on TP for and , post holdco discount, at Rs179 per share; iii) Investments in the AIF and Insurance at allocated equity book value of Rs58 and Rs40 per share, respectively; and iv) the unallocated net worth at Rs237 per share. Key risk: Integration issues from the merger due to mismatch of corporate culture and technology.
Promoters held 43.49 per cent stake in the company as of 30-Jun-2022, while FIIs owned 34.54 per cent, DIIs 8.13 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.